A parallel genome-wide RNAi screening strategy to identify host proteins important for entry of Marburg virus and H5N1 influenza virus Emerging viruses

Virology Journal

Volumn 12, Issue 1, 2015, Pages

  Cheng, Han ^a   Koning, Katie ^a   O'Hearn, Aileen ^b   Wang, Minxiu ^c   Rumschlag Booms, Emily ^d   Varhegyi, Elizabeth ^a   Rong, Lijun ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c Malcolm X College   (United States)

^d NORTHEASTERN ILLINOIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOST FACTOR; PROTEIN DERIVATIVE;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FALSE POSITIVE RESULT; GENOME ANALYSIS; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA A VIRUS (H5N1); MARBURGVIRUS; NONHUMAN; PROTEIN DETERMINATION; PSEUDOTYPING; RNA ANALYSIS; RNA INTERFERENCE; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS TYPING; GENETIC SCREENING; GENETICS; HOST PATHOGEN INTERACTION; PHYSIOLOGY; PROCEDURES;

GENETIC TESTING; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; MARBURGVIRUS; RNA INTERFERENCE; VIRUS INTERNALIZATION;

EID: 84948576437     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/s12985-015-0420-3     Document Type: Article

References (34)

1. Fauci AS. Emerging and re-emerging infectious diseases: influenza as a prototype of the host-pathogen balancing act. Cell. 2006;124:665-70.
2. Mohr S, Bakal C, Perrimon N. Genomic screening with RNAi: results and challenges. Annu Rev Biochem. 2010;79:37-64. doi: 10.1146/annurev-biochem-060408-092949.
3. Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, Castle JC, et al. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe. 2008;4(5):495-504. doi: 10.1016/j.chom.
4. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, et al. Identification of host proteins required for HIV infection through a functional genomic screen. Science. 2008;319(5865):921-6. doi: 10.1126/science.1152725.
5. Konig R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, Irelan JT, et al. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell. 2008;135(1):49-60. doi: 10.1016/j.cell.2008.07.032.
6. Hao L, Sakurai A, Watanabe T, Sorensen E, Nidom CA, Newton MA, et al. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature. 2008;454(7206):890-3.
7. Karlas A, Machuy N, Shin Y, Pleissner KP, Artarini A, Heuer D, et al. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature. 2010;463(7282):818-22. doi: 10.1038/nature08760.
8. Watanabe T, Watanabe S, Kawaoka Y. Cellular networks involved in the influenza virus life cycle. Cell Host Microbe. 2010;7:427-39. doi: 10.1016/j.chom.2010.05.008.
9. Konig R et al. Human host factors required for influenza virus replication. Nature. 2010;463:813-7. doi: 10.1038/nature08699.
10. Friedel CC, Haas J. Virus-host interactomes and global models of virus-infected cells. Trends Microbiol. 2011;19:501-8. doi: 10.1016/j.tim.2011.07.003.
11. Manicassamy B, Rong L. Expression of Ebolavirus glycoprotein on the target cells enhances viral entry. Virol J. 2009;6:75.
12. Manicassamy B, Wang J, Jiang H, Rong L. Comprehensive Analysis of Ebola Virus GP1 in Viral Entry. J Virol. 2005;79:4793-805.
13. Guo Y, Rumschlag-Booms E, Wang J, Xiao H, Yu J, Wang J, et al. Analysis of hemagglutinin-mediated entry tropism of H5N1 avian influenza. Virol J. 2009;6(1):39.
14. Basu A, Li B, Mills DM, Panchal RG, Cardinale SC, Butler MM, et al. Identification of a small-molecule entry inhibitor for filoviruses. J Virol. 2011;85(7):3106-19. doi: 10.1128/JVI.01456-10.
15. Basu A, Antanasijevic A, Wang M, Li B, Mills DM, Ames JA, et al. New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion. J Virol. 2014;88(3):1447-60. doi: 10.1128/JVI.01225-13.
16. Chan SY, Speck RF, Ma MC, Goldsmith MA. Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J Virol. 2000;74:4933-7.
17. Martinez O, Johnson J, Manicassamy B, Rong L, Olinger GG, Hensley LE, et al. Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition. Cell Microbiol. 2010;12(2):148-57. doi: 10.1111/j.1462-5822.2009.01385.x.
18. Wang J, Cheng H, Ratia K, Varhegyi E, Hendrickson WG, Li J, et al. A comparative high-throughput screening protocol to identify entry inhibitors of enveloped viruses. J Biomol Screen. 2014;19(1):100-7. doi: 10.1177/1087057113494405.
19. Guo Y, Tisoncik J, McReynolds S, Farzan M, Prabhakar BS, Gallagher T. Identification of a new region of SARS-CoV S protein critical for viral entry. J Mol Biol. 2009;394(4):600.
20. Manicassamy B, Wang J, Rumschlag E, Tymen S, Volchkova V, Volchkov V, et al. Characterization of Marburg virus glycoprotein in viral entry. Virology. 2007;358(1):79-88.
21. Zhang JH, Chung TD, Oldenburg KR. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen. 1999;4:67-73.
22. Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science. 2005;308:1643-5.
23. O'Hearn A, Wang M, Cheng H, Lear-Rooney CM, Koning K, Rumschlag-Booms E, et al. Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry. J Virol. 2015;89(10):5441-9. doi: 10.1128/JVI.03689-14.
24. Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G, Mulherkar N et al. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature. 2011. doi: 10.1038/nature10348.
25. Cote M, Misasi J, Ren T, Bruchez A, Lee K, Filone CM et al. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature. 2011. doi: 10.1038/nature10380.
26. Chan SY, Empig CJ, Welte FJ, Speck RF, Schmaljohn A, Kreisberg JF, et al. Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses. Cell. 2001;106(1):117-26.
27. Kondratowicz AS, Lennemann NJ, Sinn PL, Davey RA, Hunt CL, Moller-Tank S, et al. T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. Proc Natl Acad Sci U S A. 2011;108(20):8426-31. doi: 10.1073/pnas.
28. Simmons G, Rennekamp AJ, Chai N, Vandenberghe LH, Riley JL, Bates P. Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection. J Virol. 2003;77(24):13433-8.
29. Snijder B, Sacher R, Ramo P, Liberali P, Mench K, Wolfrum N, et al. Single-cell analysis of population context advances RNAi screening at multiple levels. Mol Syst Biol. 2012;8:579. doi: 10.1038/msb.2012.9.
30. Zhang XD, Espeseth AS, Johnson EN, Chin J, Gates A, Mitnaul LJ, et al. Integrating experimental and analytic approaches to improve data quality in genome-wide RNAi screens. J Biomol Screen. 2008;13(5):378-89. doi: 10.1177/1087057108317145.
31. Wu Z, Liu D, Sui Y. Quantitative assessment of hit detection and confirmation in single and duplicate high-throughput screenings. J Biomol Screen. 2008;13:159-67. doi: 10.1177/1087057107312628.
32. He J, Choe S, Walker R, Di Marzio P, Morgan DO, Landau NR. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol. 1995;69(11):6705-11.
33. Connor RI, Chen BK, Choe S, Landau NR. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology. 1995;206:935-44.
34. Birmingham A, Selfors LM, Forster T, Wrobel D, Kennedy CJ, Shanks E, et al. Statistical methods for analysis of high-throughput RNA interference screens. Nat Methods. 2009;6(8):569-75. doi: 10.1038/nmeth.1351.